A Randomised standard controlled comparative clinical study to evaluate the adjuvant effect of Sarpagandha Mishrana along with conventional anti hypertensive therapy in the management of essential hypertension

未提供1 个研究点分布在 1 个国家目标入组 44 人开始时间: 2026年3月1日最近更新: 2026年1月24日

试验速览

阶段: 2/3 期
状态: 尚未招募
入组人数: 44
试验地点: 1

研究概览研究设计入排标准研究者研究点记录与标识符相似试验

研究概览

简要总结

This study is a randomized standard controlled comparative clinical study to evaluate the adjuvant effect of Sarpagandha Mishrana along with conventional anti-hypertensive therapy in the managemnt of Essential Hypertension, that will be conducted in BLDEAS AVS Ayurveda Mahavidyala Hospital and Research Vijayapura 586109 Karnataka India

研究设计

研究类型: Interventional
分配方式: Randomized
盲法: None

入排标准

年龄范围: 18.00 Year(s) 至 79.00 Year(s)（—）
性别: All

入选标准

•1.Patient taking Amlodipine but not achieving desired results are included.
•2.Patients diagnosed as Essential Hypertension as per diagnostic criteria.
•3.Subjects willing and able to participate in the study.

排除标准

•1.Secondary Hypertension.
•2.Patients with a prior diagnosis of severe or malignant hypertension, moderate hypertension associated with complications, cerebrovascular disorders, coronary artery diseases, kidney conditions, heart failure, cardiomyopathy, pre-eclampsia or eclampsia, diabetes mellitus, retinopathy, or any other coexisting physical or mental health condition.

研究者

发起方

未提供

责任方

Principal Investigator

主要研究者

Dr Biradar Varsha Ravikumar

BLDEAS AVS Mahavidyala Hospital and research center

研究点 (1)

Loading locations...

相似试验

尚未招募

2 期

A Clinical Trial to study the safety and efficacy of HDLD-092320 Tablet in patients with Drug Induced Liver Injury (an injury of the liver that may occur when you take certain medicines).

CTRI/2025/02/081368Himalaya Wellness Company120

尚未招募

Phase 3 4

Comparative Evaluation Of Efficacy Of Adjuvant Role Of Dantimooladi Dhoom In The Managment Of Bronchitis (Kaphaja Kasa)

CTRI/2024/11/076313Mahatma Gandhi Ayurveda Colleege And Hospital And Research Center Salod Hirapur Wardha60

招募中

2 期

A Phase II study of post-operative palbociclib as an alternative to chemotherapy in older patients with localized breast cancer at high risk of relapse

2023-505223-31-00European Organisation For Research And Treatment Of Cancer347

招募中

4 期

A Single center, Open-Label, Randomized Study to Evaluate the Safety and Efficacy of neoadjuvant and adjuvant Pembrolizumab on top of standard Chemo-Radiotherapy (Stupp protocol) in Treatment of Patients with newly diagnosed Glioblastoma Multiforme (GBM). (PIRG)Glioblastoma Multiforme

2024-517535-52-00Medical University Of Silesia Katowice Poland36

尚未招募

2 期

Darolutamide ± ADT as Neoadjuvant Therapy in High-Risk/Very High-Risk Localized Prostate CancerProstate Cancer

NCT07476677Cancer Institute and Hospital, Chinese Academy of Medical Sciences60